References
- Mauch P M, Kalish L A, Marcus KC, et al. Long-term survival in Hodgkin's disease: Relative impact on mortality, second tumors, infection and cardiovascular disese. Cancer J Sci Am 1995; 1: 33–42
- Hudson M A, Poquette C A, Lee J, et al. Increased mortality after succesful treatment for Hodgkin's disease. J Clin Oncol 1998; 16: 3592–3600
- Avilés A, Neri N, Cuadra I, et al. Second lethal events associated with treatment for Hodgkin's disease. Leuk Lymph 2000, in press
- Breslow N E, Takashima J R, Whitton JA, et al. Second malignant neoplams following treatment for Wilm's tumor. A report from the National Wilm's Tumor Study Group. J Clin Oncol. 1995; 13: 1851–1859
- Robertson C M, Hawkins M M, Kingston JE, et al. Late deaths and survival after childhood cancer. Implication for cure. BMJ 1994; 309: 162–166
- Hudson M M, Jones D, Boyett J, et al. Late mortality of long-term survivors of childhood cancer. J Clin Oncol 1997; 15: 1997, 2207–2213
- Nicholson H S, Fears T R, Byrne J. Death during adulthood in survivors of childhood and adolescent cancer. Cancer 1994; 73: 1994, 3094–3102
- Dumontet C, Bastion Y, Felman P, et al. Long-term outcome and sequelae in aggressive lymphoma patients treated with the LNH-80 regimen. Ann Oncol 1992; 3: 639–644
- Handy T B, Adde M A, McCall J, et al. Late effects in long-term survival of high grade non-Hodgkin's lymphoma. J Clin Oncol 1998; 16: 2070–2079
- Avilés A, Arévila N, Díaz-Maqueo JC, et al. Late cardiac toxicity of doxorubicin, epirubicin and mitoxantrone therapy for Hodgkin's disease in adults. Leuk Lymph 1993; 11: 275–279
- Avilés A, Díaz-Maqueo J C, Ródriguez L, et al. Group-risk classification of non-Hodgkin's lymphoma. Arch Invest Med 1990; 21: 11–16
- The International non-Hodgkin's lymphoma Prognostic Factor. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987–994
- Avilés A, Delgado S, Nambo MJ, et al. Adjuvant radiotherapy to sites of previous bulky disease in patients with stage IV diffuse large cell lymphoma. Int J Radiat Oncol Biol Phys 1994; 30: 799–804
- Kaplan E L, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481
- Peto R, Pike M L, Armitage P, et al. Desing and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1–39
- Mantel N, Haenzel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719–748
- Kalbfleisch J A, Prentice RL. The statistical analysis of failure time data. Wiley, New York, NY 1980; 169
- Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141–1154
- Breslow N E, Day NE. Statistical methods in cancer research. Vol II: The desing and analysis of cohort studies. International Agency for Research in Cancer, LyonFrance 1987
- Avilés A, García R. Late evaluation of carditoxicity in patients with malignant lymphoma treated with intensive chemotherapy. Cancer Res Ther Control 1999; 10: 1999, 119–122